Urimust D 0.4mg/0.5mg Tablet MD

Overview Urimust D 0.4mg/0.5mg Tablet MD

ProstaDuo 0.4mg/0.5mg tablets are a dual-action medication designed for male patients with benign prostatic hyperplasia (BPH). This treatment alleviates bothersome urinary symptoms like frequent urination and difficulty emptying the bladder. It does not prevent prostate cancer. ProstaDuo 0.4mg/0.5mg tablets can be administered with or without food, but consistent daily timing is crucial. Your physician will determine the appropriate dosage. For optimal symptom management, consistent daily use is vital, even during periods of feeling well. Symptom improvement may take up to four weeks; continue regular use. Report any lack of improvement or symptom worsening after four weeks to your doctor. Common side effects include erectile dysfunction, reduced libido, breast tenderness, and ejaculatory problems. Contact your doctor if these side effects are bothersome or persistent. Dizziness or drowsiness are also possible, particularly when initiating treatment. Your doctor prescribed this medication because the potential benefits outweigh the risks. ProstaDuo 0.4mg/0.5mg tablets are not for use by women or children. Inform your doctor of any pre-existing conditions such as low blood pressure, liver, or kidney disease before commencing treatment, as this medication may be unsuitable. It may interact with other medications; therefore, disclose all current medications to your doctor. Condom use during sexual intercourse is recommended if your partner is, or could be, pregnant. Regular blood pressure monitoring may be advised. Alcohol consumption should be avoided due to the increased risk of dizziness.

Primary Ingredients of Urimust D 0.4mg/0.5mg Tablet MD

No text provided. Please provide the text you wish to be rephrased.

Uses of Urimust D 0.4mg/0.5mg Tablet MD

Managing benign prostatic hyperplasia

Major Benefits of Urimust D 0.4mg/0.5mg Tablet MD:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Avoid handling the tablets with damp hands. Place the tablet in your mouth; however, refrain from swallowing immediately. Urimust D 0.4mg/0.5mg Tablet MD can be ingested with or without food, though consistent timing is recommended for optimal results.

Common Side effects of Urimust D 0.4mg/0.5mg Tablet MD:

• Impotence
• Decreased libido
• Ejaculation disorder
• Orthostatic hypotension (sudden lowering of blood pressure on standing)
• Breast enlargement in male
• Breast tenderness in male
• Dizziness

How to use Urimust D 0.4mg/0.5mg Tablet MD:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Avoid contact with the tablets using damp hands. Place the tablet in your mouth; however, refrain from immediate swallowing. Urimust D 0.4mg/0.5mg Tablet MD can be consumed with or without food, although consistent timing is recommended.

How Urimust D 0.4mg/0.5mg Tablet MD works:

Urimust D 0.4mg/0.5mg tablets combine Tamsulosin and Dutasteride to alleviate benign prostatic hyperplasia symptoms. Tamsulosin, an alpha-blocker, eases urine flow by relaxing bladder neck and prostate muscles. Dutasteride, a 5-alpha-reductase inhibitor, reduces prostate size by lowering levels of the hormone stimulating prostate growth.

What if you forget to take Urimust D 0.4mg/0.5mg Tablet MD :

Should you forget a dose of Urimust D 0.4mg/0.5mg Tablet MD, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.